Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. (Q44018168)
Jump to navigation
Jump to search
scientific article published on 4 September 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. |
scientific article published on 4 September 2001 |
Statements
1 reference
Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. (English)
1 reference
Pneumocystis Carinii
1 reference
G S Leoung
1 reference
J F Stanford
1 reference
M F Giordano
1 reference
A Stein
1 reference
R A Torres
1 reference
C A Giffen
1 reference
M Wesley
1 reference
T Sarracco
1 reference
E C Cooper
1 reference
V Dratter
1 reference
J J Smith
1 reference
K R Frost
1 reference
American Foundation for AIDS Research (amfAR) Community-Based Clinical Trials Network
1 reference
4 September 2001
1 reference
1 reference
184
1 reference
8
1 reference
992-997
1 reference
Identifiers
1 reference
1 reference